Paul F. Lizzul
CIK 1711462 · Chief Medical Officer · last filed 2026-05-14
Paul F. Lizzul is a Chief Medical Officer who has filed 28 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing, for TRAX, was dated May 14, 2026. Across all open-market trades the lifetime net is −$745.2K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.36M
3
28
-$745.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TRAX | Chief Medical Officer | 42,669 | — | — | $0 | 2 | 2026-05-14 |
| ANAB | Chief Medical Officer | 42,088 | $56.07 | $2.36M | -$895.2K | 20 | 2026-01-09 |
| Sienna Biopharmaceuticals, Inc. (SNNA) Delisted | Chief Medical Officer | 207,045 | — | — | $150.0K | 6 | 2019-08-08 |
Recent Filings
28 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-14 | TRAX | Grant (A) | — | $0 | EDGAR |
| 2026-04-22 | TRAX | Grant (A) | — | $0 | EDGAR |
| 2026-01-09 | ANAB | Mixed | +4,875 | -$163.2K | EDGAR |
| 2026-01-08 | ANAB | Mixed | +3,910 | -$100.8K | EDGAR |
| 2026-01-06 | ANAB | Mixed | +6,336 | -$182.5K | EDGAR |
| 2025-12-23 | ANAB | Mixed | — | -$47.2K | EDGAR |
| 2025-01-07 | ANAB | Mixed | +10,103 | -$97.9K | EDGAR |
| 2024-09-24 | ANAB | Mixed | — | -$30.3K | EDGAR |
| 2024-09-17 | ANAB | Mixed | +3,780 | -$86.4K | EDGAR |
| 2024-08-16 | ANAB | Mixed | — | -$43.0K | EDGAR |